Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition
Clinical trial NCT03926117 · COMPLETED
Trial details
- NCT number
- NCT03926117
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2020-06-26
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.